• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Small Innovators & Niche CROs

    Focus on Science

    Rapid and Data Rich Chromatographic Method Development

    Preparing Your Post Pandemic Talent Strategy

    How Modern Near-Infrared Came to Be
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Frontage Expands Capabilities at its Clinical Site in Secaucus, NJ

    Ascendia Pharmaceuticals Poised for Expansion

    Bora Pharmaceuticals Adds Roller Compaction Capabilities

    Merck KGaA Selects PRA’s Remote Patient Monitoring Platform

    AGC Biologics Appoints Jun Takami GM of Chiba Site
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Ascendia Pharmaceuticals Poised for Expansion

    Bora Pharmaceuticals Adds Roller Compaction Capabilities

    Alkermes, Merck Enter Clinical Trial and Supply Agreement

    Sterling Pharma Solutions Acquires ADC Biotechnology

    Moderna, Catalent Enter Long-Term Strategic Vax Pact
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Cryoport Acquires Critical Transport Solutions Australia

    PharmParts – This Makes Sense!

    Securing Your API Supply Chain: Three Keys to Success

    Enteris BioPharma: Custom Solutions – From Bench to Market

    The Benefits of Outsourcing Cold Storage
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Frontage Expands Capabilities at its Clinical Site in Secaucus, NJ

    Ascendia Pharmaceuticals Poised for Expansion

    Merck KGaA Selects PRA’s Remote Patient Monitoring Platform

    Agilex Biolabs Acquires TetraQ for APAC Expansion Plans

    Alkermes, Merck Enter Clinical Trial and Supply Agreement
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    What Will Change at FDA for 2021?

    RBQM Comes of Age: COVID as a Catalyst for Change

    Post-Pandemic Regulations

    Enteris BioPharma: Custom Solutions – From Bench to Market

    Metrics Contract Services Completes Russian Regulatory Inspection
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Reed-Lane

    Baxter BioPharma Solutions

    Aphena Pharma Solutions

    Almac Group

    Syngene
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Aphena Pharma Solutions

    Adare Pharma Solutions

    PCI Pharma Services

    Alcami

    Quotient Sciences
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Expert's Opinion

    Technological Arms Race Could Improve Bio Process Mfg. Efficiency

    Experts warn bio industry needs to do more to create a sustainable pipeline of talent

    Related CONTENT
    • Sound Pharmaceuticals Receives $3.1M NIH Grant for COVID Treatment
    • SK Capital Completes Acquisition of BFS from Catalent Pharma Solutions
    • AstraZeneca, Aji Bio-Pharma Expand Mfg. Agreement
    • Asymchem Expands Oligonucleotides Mfg. Capacity
    • Eisai Begins Construction of New Injection/Research Building
    06.29.18
    A report from bioLIVE has collected findings from a panel of experts to identify a number of potential applications of small molecule expertise that should be applied to the biologics industry. The report forecasts the increasing role outsourcing will play in the bio supply chain and how continuous processing, API and process analytical technology (PAT) expertise will be integral to future growth.

    Establishing a sustainable pipeline of qualified staff into the rapidly maturing biologics supply chain has been identified as a key issue. Data from the 2018 BioPlan Associates Annual Survey identified three key areas where small molecule expertise could see cross industry benefits - 'process control' (33%), 'quality management' (30%), and 'training operators and technicians' (29%).

    Emil Ciurczak of Doramaxx Consulting, a CPhI Annual Report expert, argues this is only the tip of the iceberg, and that if the question were to be reversed-i.e. asking small molecule experts about the areas where their technology could be of use to the large molecule industry-that the positive responses would be much higher.

    "Although the positive response data from biopharmaceutical manufacturers may not appear that high, this could be due to a lack of familiarity with the level of expertise of technology available to them, rather than a firm understanding of the sector and a discounting of its relevance," said Mr. Ciurczak. "For instance, Raman and NIRS (near-infrared spectroscopy) could be used for the testing of incoming raw materials, checking clinical supplies, and-comparing fermentation to API synthesis-monitoring a reaction even if final release is by compendial methods.

    He also identified the implementation of PAT as a key area for greater collaboration, adding that "indeed, the U.S. FDA plainly stated that the Guidances and ICH Q8, 9, and 10 were designed for small molecules. Consequently, a 'pure' biologics company will not have direct experience with PAT and there is a time gap in familiarity." But he warned that "the bio industry needs to do more to attract talent, as seldom do small molecule personnel switch careers to work in Biopharma companies."

    With the industry still debating on how best to bring CAR-T therapies, among others, into commercial production, Girish Malhotra argued that the small molecule industry's 50+ years of manufacturing pedigree can bring vital contributions. Examining the emergence of continuous bioprocessing, Mr. Malhotra said, "Bio manufacturers will need experienced fermentation masters, chemists and chemical engineers who understand finances, process development and process simplification values."

    Another surprising area for cross-industry collaboration is between API experts and bio, as the instruments used for chemical and physical measurements for API production may only need minor alterations to be useful in fermentations. "Continuous chromatography, which is beginning to become more common in API work, could also be used in bioprocesses," said Mr. Ciurczak.

    The report predicts that over the next few years we will likely see a "technological arms race" among outsourcing providers to help increase efficiencies, lower costs and decrease clinical timelines in bio development and manufacturing. To take just one example, technologies that help reduce the cost of the expensive protein A capture step in biomanufacturing could potentially represent a huge process improvement.

    In terms of contract manufacturing, the report foresees cell and gene CDMOs growing quickly, all be it from a low base-especially as more products enter commercial stage. Another approach to differentiate and achieve growth for smaller bio CDMOs is novel technologies that speed production and lower costs. Already we have seen big pharma partnering with a number of smaller biotechs for anything from AI technologies to 3D micro-organoid modelling and bio process improvements-the latter is where there will likely be a new arms race for the best technologies amongst outsourcing providers. Big pharma will also seek to mirror its approach in the small molecule industry, and mitigate supply chain risk, by seeking to partner with several CDMOs in both development and commercialization of its most profitable new targets.

    "We are only just now beginning to see the potential of a cross industry collaboration between these two formerly distinct industries. And our experts are only just starting to explore the ways in which these two industries could collaborate to improve production timelines, efficiencies and regulatory compliance," said Rutger Oudejans, brand director pharma at UBM. "Already there is a consensus that API technology could be applicable and that bio companies should encourage more small molecule experts into the industry as it grows. Particularly, those with PAT and process development expertise. That is without even considering how the two pipelines are becoming increasingly blurred with peptides and ADCs. A key part of our value proposition with bioLIVE is to open the debate and increasingly foster collaborations between the two. With our co-located events, CPhI and ICSE - API & contract services respectively - the complete supply chain will be able to meet new partners. This will prove essential to a quickly maturing bio supply chain, and will be key to future development."

    bioLIVE is the new UBM (part of Informa PLC) biomanufacturing and bioprocessing event taking place in Madrid October 9-11, 2018. For more information visit https://www.bio.live
    Related Searches
    • pipeline
    • events
    • Process Development
    • supply chain
    Suggested For You
    Sound Pharmaceuticals Receives $3.1M NIH Grant for COVID Treatment Sound Pharmaceuticals Receives $3.1M NIH Grant for COVID Treatment
    SK Capital Completes Acquisition of BFS from Catalent Pharma Solutions SK Capital Completes Acquisition of BFS from Catalent Pharma Solutions
    AstraZeneca, Aji Bio-Pharma Expand Mfg. Agreement  AstraZeneca, Aji Bio-Pharma Expand Mfg. Agreement
    Asymchem Expands Oligonucleotides Mfg. Capacity Asymchem Expands Oligonucleotides Mfg. Capacity
    Eisai Begins Construction of New Injection/Research Building Eisai Begins Construction of New Injection/Research Building
    Evotec, Takeda Enter Multi-RNA Target Alliance Evotec, Takeda Enter Multi-RNA Target Alliance
    Outsourcing Solid Dosage Manufacturing Outsourcing Solid Dosage Manufacturing
    Oakwood Labs Oakwood Labs
    Fusion Pharmaceuticals Acquires IPN-1087 Fusion Pharmaceuticals Acquires IPN-1087
    Lonza Expands Solid Small Molecule Services Lonza Expands Solid Small Molecule Services
    CDMO Recro Strengthens Leadership Team CDMO Recro Strengthens Leadership Team
    Jubilant Biosys, Yale Form Research Alliance Jubilant Biosys, Yale Form Research Alliance
    Targeted Protein Degradation at Syngene Targeted Protein Degradation at Syngene
    Catalent Divests Blow-Fill-Seal Sterile CDMO Business Catalent Divests Blow-Fill-Seal Sterile CDMO Business
    Angelini Pharma Acquires Arvelle Therapeutics for $960M Angelini Pharma Acquires Arvelle Therapeutics for $960M

    Related Expert's Opinion

    • Biologics, Proteins, Vaccines | Cold Chain Management | Logistics | Supply Chain
      Rising to The Occasion: The High Stakes of Vaccine Transport

      Rising to The Occasion: The High Stakes of Vaccine Transport

      How logistical precision can ensure safe and efficient delivery of the COVID-19 vaccine.
      Bill Brooks, Vice President of North America Transportation Portfolio at Capgemini 11.04.20

    • Biologics, Proteins, Vaccines | Drug Development
      The Importance of Global Collaboration in the Fight Against COVID-19

      The Importance of Global Collaboration in the Fight Against COVID-19

      Industry continues to join forces to find new treatments for COVID-19.
      Dohyun Cho, Chief Operating Officer, Enzychem Lifesciences 09.08.20

    • Biologics, Proteins, Vaccines | Clinical Trials | Drug Development
      Global Biotech: Leading Health Care Innovation and How CROs Are Adapting to Meet Their Needs

      Global Biotech: Leading Health Care Innovation and How CROs Are Adapting to Meet Their Needs

      New models from CROs are enabling further biotech expansion
      Davide Garrisi, Biotech Portfolio Lead, PPD Biotech 08.20.20


    • Biologics, Proteins, Vaccines | cGMP Manufacture | Drug Development
      Tackling Analytical Challenges in Gene Therapy

      Tackling Analytical Challenges in Gene Therapy

      Key considerations on how to navigate the field as a gene therapy developer.
      Khanh Ngo Courtney, Ph.D., Biologics Project Director, Avomeen 07.17.20

    • Biologics, Proteins, Vaccines | cGMP Manufacture | Logistics | Supply Chain
      New Supply Chain Considerations in Response to COVID-19

      New Supply Chain Considerations in Response to COVID-19

      Cell & gene therapy companies have faced unique challenges due to the nature of their therapies, this is especially true for autologous cell therapies.
      Mark Stielow, Senior Director of Cell Manufacturing & Technical Operations, Adaptimmune 06.10.20

    • Biologics, Proteins, Vaccines | Clinical Trials | Drug Development | Logistics
      The Importance of CAR-T Cell Therapy in Clinical Trials

      The Importance of CAR-T Cell Therapy in Clinical Trials

      The Industry’s Evolving, Maturing Focus
      Panteli Theocharous, Global Vice President, Cell and Gene Therapy Strategy Lead, PPD 05.26.20


    • Biologics, Proteins, Vaccines | Drug Development | Information Technology
      Speeding Vaccine Development with Advanced Analytics

      Speeding Vaccine Development with Advanced Analytics

      Having immediate access to wide ranging resources of data can help speed the COVID-19 vaccine development process
      Dr. Shlomi Madar, VP of Healthcare Solutions, Signals Analytics 04.15.20

    • Biologics, Proteins, Vaccines | cGMP Manufacture | Drug Development | Scale-up/Technology Transfer
      Robust Response to COVID-19 Demand

      Robust Response to COVID-19 Demand

      What it’s going to take to develop, scale-up, and manufacture the products needed to address the COVID-19 outbreak.
      Christa Myers, Pharmaceutical Market Sector Lead, CRB 03.31.20

    • Biologics, Proteins, Vaccines | Drug Development
      Immunogenicity Assessment of Gene Therapy Compounds

      Immunogenicity Assessment of Gene Therapy Compounds

      Dr. Kromminga of BioAgilytix discusses testing challenges and evolving trends in gene therapy.
      Dr. Arno Kromminga, global chief scientific officer, BioAgilytix 11.27.19


    • Biologics, Proteins, Vaccines | Clinical Trials
      Advanced Therapies: Adding a New Layer of Complexity to Clinical Trials

      Advanced Therapies: Adding a New Layer of Complexity to Clinical Trials

      Overcoming the challenges of a new and changing clinical trial landscape
      Erin Finot, Global Head of Immuno-Oncology, IQVIA Biotech 11.18.19

    • Biologics, Proteins, Vaccines | cGMP Manufacture | Clinical Trial Materials | Scale-up/Technology Transfer
      The Pain-Free Guide: Transitioning from Clinical Production to Commercial Manufacturing

      The Pain-Free Guide: Transitioning from Clinical Production to Commercial Manufacturing

      Cell and gene therapy facilities face a unique set of challenges as they scale towards commercial production and require equally unique solutions
      Peter Walters , Lead Process Engineer, CRB USA 11.11.19

    • Biologics, Proteins, Vaccines | cGMP Manufacture | Drug Development
      Continued and Consistent Investment in Manufacturing Facilities

      Continued and Consistent Investment in Manufacturing Facilities

      As companies move their cell and gene therapies through the development process, supporting larger Phase III trials and commercial launches will be a challenge
      Ryan Carpentier, Executive Director of Business Development, Cryoport 09.23.19


    • Biologics, Proteins, Vaccines | Cold Chain Management | Drug Development | Supply Chain
      CAR T for Large Tumors: The Next Frontier?

      CAR T for Large Tumors: The Next Frontier?

      Ryan Carpentier of Cryoport discusses the successes and the challenges these exciting new therapies present
      Ryan Carpentier, Executive Director of Business Development at Cryoport 09.10.19

    • Biologics, Proteins, Vaccines | cGMP Manufacture | Drug Development | GMPs/GCPs | Regulatory Affairs
      Knowledge Sharing in the Development and Delivery of Biologics

      Knowledge Sharing in the Development and Delivery of Biologics

      The increasing importance of sharing information to build awareness and better manage the complexities of drug development
      Fran L. DeGrazio, Vice President, Scientific Affairs & Technical Services, West Pharmaceutical Services, Inc. 07.15.19

    • Biologics, Proteins, Vaccines | Drug Development
      The Missing Piece in Rare-Disease Drug Development

      The Missing Piece in Rare-Disease Drug Development

      More genetics expertise is crucial in getting these drugs to market.
      Jill Johnston, President, Site Activation Solutions, WCG Clinical Services and Karmen Trzupek, Director, Ocular & Rare Disease Genetics Services, InformedDNA 08.22.18

    Trending
    • Sterling Pharma Solutions Acquires ADC Biotechnology
    • Ascendia Pharmaceuticals Poised For Expansion
    • Sanofi To Build New $700M Flu Vaccine Facility In Canada
    • Frontage Expands Capabilities At Its Clinical Site In Secaucus, NJ
    • Merck KGaA Selects PRA’s Remote Patient Monitoring Platform
    Breaking News
    • Bora Pharmaceuticals Adds Roller Compaction Capabilities
    • Ascendia Pharmaceuticals Poised for Expansion
    • Frontage Expands Capabilities at its Clinical Site in Secaucus, NJ
    • Merck KGaA Selects PRA’s Remote Patient Monitoring Platform
    • AGC Biologics Appoints Jun Takami GM of Chiba Site
    View Breaking News >
    CURRENT ISSUE

    April 2021

    • Small Innovators & Niche CROs
    • Focus on Science
    • Rapid and Data Rich Chromatographic Method Development
    • Preparing Your Post Pandemic Talent Strategy
    • How Modern Near-Infrared Came to Be
    • Securing Your API Supply Chain: Three Keys to Success
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Kyowa Hakko Launches Heat-Treated Probiotic Strain for Eye Health
    CGA-7 Green Coffee Extract by Vidya Herbs Achieves Self-Affirmed GRAS Status
    Nutritional Complex Evidenced to Reduce Preterm Birth
    Coatings World

    Latest Breaking News From Coatings World

    Chromaflo Technologies to Sponsor and Exhibit at the North American Pultrusion Conference 2021
    Barentz Expands Canadian CASE Team
    Shepherd Color Company Opens Sales Office in China
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    CMS Establishes New Payment for Pelvalon’s Eclipse System
    Varian, Google Cloud Partner to Bring Convenience to Cancer Therapy
    Resonetics Leases New Manufacturing Space in Costa Rica
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Frontage Expands Capabilities at its Clinical Site in Secaucus, NJ
    Ascendia Pharmaceuticals Poised for Expansion
    Bora Pharmaceuticals Adds Roller Compaction Capabilities
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Revlon Unveils New Fragrances Featuring Megan Thee Stallion & Sofia Carson
    Henkel Management Board Welcomes Wolfgang König
    Mielle Organics Gets a Major Investment
    Happi

    Latest Breaking News From Happi

    Nature’s Beauty Debuts Vegan Natural Body Care at Walgreens
    Estée Lauder Expands Beautiful Fragrance Collection
    The Honest Company Files for IPO
    Ink World

    Latest Breaking News From Ink World

    SE-DA Invests in Kornit Presto S
    Kumon North America Adds Speedmaster XL 106 from Heidelberg
    Iron Oxide Pigments Market to Register 4.7% CAGR from 2021 to 2028: GVR
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Dantex elevates Joseph Sanchez to digital business development manager
    Mactac's Kevin Clunie joins TLMI panel
    MacDermid announces two new global sales roles
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Precision Textiles Offers Biodegradable Medical Fabric
    Northshore Launches Megamax Briefs in New Colors
    Essity Acquires Distribution Rights to Sorbact in Australia and New Zealand
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    New Biosealant Could Stabilize Cartilage, Boost Healing After Injury
    Google Executive Joins SeaSpine's Board of Directors
    HSS and LimaCorporate Open Provider-Based 3D Design and Printing Facility
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Tive Multi-sensor Tracker Solo 5G Relies on Sensirion SHT33
    VTT in 2020: Successful Year Despite Globally Challenging Times
    Lux Research: 3D Printing Market to Reach $51 Billion in 2030

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login